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Abstract
BACKGROUND—Despite worldwide consumption of moderate amounts of alcohol, the neural 
mechanisms that mediate the transition from use to abuse are not fully understood.
METHODS—Here, we conducted a high-through put screen of the amygdala proteome in mice 
after moderate alcohol drinking (n = 12/group) followed by behavioral studies (n = 6–8/group) to 
uncover novel molecular mechanisms of the positive reinforcing properties of alcohol that 
strongly influence the development of addiction.
RESULTS—Two-dimensional difference in-gel electrophoresis with matrix assisted laser 
desorption ionization tandem time-of-flight identified 29 differentially expressed proteins in the 
amygdala of nondependent C57BL/6J mice following 24 days of alcohol drinking. Alcohol-
sensitive proteins included calcium/calmodulin-dependent protein kinase II alpha (CaMKIIα) and 
a network of functionally linked proteins that regulate neural plasticity and glutamate-mediated 
synaptic activity. Accordingly, alcohol drinking increased α-amino-3-hydroxy-5-methyl-4-
isooxazole receptor (AMPAR) in central amygdala (CeA) and phosphorylation of AMPAR GluA1 
subunit at a CaMKII locus (GluA1-Ser831) in CeA and lateral amygdala. Further, CaMKIIα-
Thr286 and GluA1-Ser831 phosphorylation was increased in CeA and lateral amygdala of mice 
that lever-pressed for alcohol versus the nondrug reinforcer sucrose. Mechanistic studies showed 
that targeted pharmacologic inhibition of amygdala CaMKII or AMPAR activity specifically 
inhibited the positive reinforcing properties of alcohol but not sucrose.
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CONCLUSIONS—Moderate alcohol drinking increases the activity and function of plasticity-
linked protein networks in the amygdala that regulate the positive reinforcing effects of the drug. 
Given the prominence of positive reinforcement in the etiology of addiction, we propose that 
alcohol-induced adaptations in CaMKIIα and AMPAR signaling in the amygdala may serve as a 
molecular gateway from use to abuse.
Keywords
Addiction; Alcohol; AMPA; Amygdala; CaMKII; CaMKII alpha; GluA1; Glutamate; Mice; 
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Human beings have consumed alcohol for thousands of years; its use is deeply rooted in 
culture and religion. In developed countries, more than 50% of the adult population 
consumes alcohol on a regular basis (1) with approximately 9% developing dependence (2). 
The transition from alcohol use to abuse is a multiphasic process that is characterized 
initially by repeated intoxication episodes where the powerful positive reinforcing, or 
rewarding, effects of the drug predominate (3). Thus, defining the neural mechanisms of 
alcohol reinforcement is critical to a comprehensive understanding of the etiology of this 
debilitating neuropsychiatric disorder (4).
Although multiple neural systems regulate reinforcement processes, evidence suggests that 
drugs of abuse gain control over individuals, in part, by usurping glutamate-linked 
neurotransmission within brain reward circuits (5–7), including the extended amygdala (8). 
Indeed, chronic alcohol exposure alters glutamate release (9), receptor function (10,11), and 
glutamate-linked synaptic plasticity (12) in the amygdala. Since glutamate transmission in 
the amygdala is required for the development of new behavior and retention of actions (13), 
these neural processes may underlie the development and maintenance of alcohol-seeking 
behavior (14,15). However, the extent to which initial alcohol drinking alters mechanisms of 
glutamate-linked transmission in the amygdala and whether these neural targets of alcohol 
regulate the positive reinforcing effects of the drug remain to be characterized.
To increase understanding of the transition from use to abuse, we first employed an unbiased 
proteomic strategy to identify molecular changes that are induced in the amygdala by 
moderate voluntary alcohol drinking in C57BL/6J mice. In four parallel assays, two-
dimensional differential in-gel electrophoresis (2D-DIGE) followed by matrix assisted laser 
desorption ionization tandem time-of-flight (MALDI-TOF/TOF) mass spectrometry showed 
that alcohol drinking consistently altered expression of 29 amygdala proteins, which 
included calcium/calmodulin dependent kinase II alpha (CaMKIIα) and other proteins that 
regulate glutamate neurotransmission. CaMKII is a serine-threonine kinase that plays a 
prominent role in glutamate neurotransmission and experience-dependent plasticity at the 
synaptic and behavioral level (16), which makes it a highly significant target in the search 
for neural mechanisms of how the brain becomes focused on alcohol during the 
development of addiction (17). Moreover, proteomic studies have found overlapping 
changes in neural protein expression between rodent models of alcohol drinking (18,19) and 
postmortem human alcoholic brain (20,21), indicating significant translational value of 
preclinical approaches (22). However, it remains to be determined if alcohol-sensitive 
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protein networks mechanistically regulate alcohol-seeking behavior in a manner that might 
influence the development of addiction. Thus, after identifying CaMKIIα as a neural target 
of moderate drinking, we used operant conditioning techniques to determine if CaMKII 
signaling in the amygdala mechanistically regulates the reinforcing effects of alcohol in 
mice.
Glutamatergic α-amino-3-hydroxy-5-methyl-4-isooxazole receptors (AMPARs) play a 
major role in experience-dependent synaptic and behavioral plasticity (23). CaMKII 
phosphorylation of AMPARs at the GluA1-Ser831 subunit is required for synaptic plasticity 
and memory retention (24–26). This makes the CaMKII-AMPAR signaling pathway an 
ideal candidate for aberrant learning that characterizes addiction (27). Therefore, we also 
explored the hypothesis that alcohol-induced changes in amygdala CaMKIIα protein 
expression might be associated with increased glutamate-mediated synaptic activity and 
mechanistic regulation of alcohol reinforcement via AMPAR function within the amygdala. 
Collectively, these multidisciplinary experiments identify a novel protein network that 
includes the CaMKIIα–AMPAR pathway in the amygdala as a target of moderate alcohol 
drinking that also mechanistically regulates the positive reinforcing effects of the drug, 
which are critical to the etiology and enduring nature of alcohol use disorders.
METHODS AND MATERIALS
Additional methodological details are in Supplement 1.
Mice
Adult male C57BL/6J mice were singly (voluntary home-cage drinking) or group housed 
(operant self-administration) and treated in accordance with institutional and National 
Institutes of Health guidelines.
Voluntary Alcohol Drinking (Home-Cage)
Voluntary home-cage alcohol drinking was measured as described (28). Briefly, mice had 
home-cage ethanol (10% vol/vol) and water access for 24 days. Control mice had access to 
two water bottles. Alcohol and water intake were measured at 24-hour intervals. After the 
final access day, brains were processed for 2D-DIGE analysis, immunoblotting, or 
immunohistochemistry at the end of the 12-hour light cycle when blood alcohol content 
(BAC) was zero.
2D-DIGE Protein Expression Profiling of Amygdala—Amygdala punches (1 mm 
diameter) from alcohol or control mice were pooled (n = 3 mice per condition per sample) to 
obtain adequate protein for four 2D gels. Samples were sent to Applied Biomics, Inc 
(Hayward, California) for 2D-DIGE analysis under established protocols (Supplement 1 and 
www.appliedbiomics.com). Data are presented from protein spots that met a priori criteria: 
average relative change ≥25%, change present in all four gels, and mean change (alcohol 
versus water) was statistically significant. Proteins were identified by MALDI-TOF/TOF 
analysis (Applied Biosystems, Foster City, California).
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Immunoblotting—Amygdala punches from alcohol- or water-drinking mice were 
prepared for evaluation of CaMKIIα, calcium/calmodulin dependent kinase II beta 
(CaMKIIβ), pCaMKIIThr286, and N-ethylmaleimide sensitive factor (NSF) protein 
expression via immunoblot as reported (28). Optical density of each band was measured 
using Scion imaging software (Scion Corporation, Frederick, Maryland). Values were 
expressed as percent of glyceraldehyde-3-phosphate dehydrogenase.
Immunohistochemistry—Coronal amygdala sections were prepared from home-cage 
alcohol- (n = 6) or water-drinking (n = 6) mice for immunohistochemical analysis of 
pCaMKIIa-Thr286 and pGluA1-Ser831 as previously reported (15).
Electrophysiology—Additional mice underwent the 24-day voluntary home-cage 
alcohol- or water-drinking procedure for whole-cell voltage clamp recordings from coronal 
sections of the medial central amygdala (CeA) as detailed in Supplement 1.
Operant Alcohol Self-Administration
Training—Alcohol or sucrose self-administration sessions were conducted in operant 
conditioning chambers. Lever-press behavior was facilitated using sucrose-fading 
procedures detailed in Supplement 1. Briefly, responses were trained with sucrose-only 
reinforcement and then maintained on a fixed-ratio 4 schedule of sweetened alcohol (9% 
vol/vol ethanol + 2% wt/vol sucrose) reinforcement. Control mice were trained with sucrose 
(2% wt/vol) reinforcement. After 30 baseline sessions, separate cohorts of mice were used 
for 1) site-specific microinjections, 2) immunoblotting, or 3) immunohistochemistry.
Microinjections—Following the 30th session, mice were surgically implanted with 
bilateral injector guides aimed 2 mm above the amygdala (29). After recovery, CaMKII 
inhibitors KN-93, myristoylated autocamtide-2-related inhibitory peptide (m-AIP), or 
myristoylated CamKIINtide (m-CAMKIINtide) or the AMPAR antagonist NBQX were 
infused in the amygdala before alcohol self-administration sessions in separate groups of 
alcohol or sucrose-control mice to assess regulation of alcohol reinforcement. Potential 
nonspecific effects were assessed in a locomotor activity assay. Data are presented from 
mice verified histologically to have injection sites in the amygdala.
RESULTS
Effects of Voluntary Alcohol Drinking on the Amygdala Proteome
Alcohol Drinking—C57BL/6J mice consumed alcohol (10% vol/vol) versus water under 
home-cage 24-hour two-bottle choice conditions (28) for 24 days (Figure 1A). Total fluid 
consumption did not differ between groups (Figure 1B, top). Alcohol-exposed mice 
exhibited preference for alcohol over water (>75%) and showed stable intake at a 
subdependence dosage (12.8 ± 1.3 g/kg per 24 hours) from days 6 to 24 of access (Figure 
1B, bottom). BAC was .0 mg/dL at the onset of the 12-hour dark cycle and 39.1 mg/dL after 
6 hours in the dark. Voluntary alcohol drinking produced no major health effects as 
evidenced by normal growth in alcohol (Δ weight = 1.7 ± .6 g/day) versus water (Δ weight = 
2.1 ± .21 g/day) groups. Alcohol-drinking mice exhibited no change in plasma stress 
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hormone level at the time of sacrifice (Figure 1C) or withdrawal symptoms (30), suggesting 
absence of dependence.
Differentially Expressed Proteins in Amygdala—Amygdala tissue punches (Figure 
1D) were taken from alcohol and water-only exposed mice at the onset of the dark cycle on 
day 25 (Figure 1A). Tissue was pooled (n = 3 per sample per condition) and whole-cell 
lysates were compared between water and alcohol exposed mice on four replicate gels via 
2D-DIGE. Differential in-gel image analysis using DeCyder software (GE Healthcare Bio-
Sciences, Pittsburgh, Pennsylvania) identified 30 spots that met the a priori criterion for 
selection, and 29 were identified using MALDI-TOF/TOF (Figure 1E; Table 1, spots 2–30). 
Differential in-gel image analysis showed that expression ratios (alcohol/water) ranged from 
−2.03-fold to 1.72-fold with 14 proteins showing significant decreased expression and 15 
showing increased expression (Table 1). Cross-gel normalization was conducted via 
comparison of an internal standard made up of equal amounts of each sample (alcohol + 
water) on each gel, which showed that CaMKIIα expression was increased more than five-
fold in alcohol-exposed mice (Figure 1F).
Bioinformatics—Protein identifiers, fold-change, and p values were submitted to 
Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, Redwood City, California) for 
dataset enrichment. Cellular location of proteins was classified as follows: nucleus (2 
proteins), cytoplasm (22 proteins), plasma membrane (4 proteins), and other (1 protein) 
(Table 1). Two networks of known protein-protein interactions related to cell signaling (14 
proteins) and cell morphology (8 proteins) were associated with alcohol drinking (Table 2). 
Protein-protein interactions within the alcohol-sensitive network related to cell signaling and 
interaction, nervous system development and function, and behavior were visualized using 
the IPA pathway designer and indicate key interactions, including CaMKIIα modulation of 
AMPAR GRIA1 (GluA1) subunit (Figure S1 in Supplement 1). Functional clusters were 
identified by IPA related to known diseases and disorders, molecular and cellular functions, 
and canonical pathways with potential upstream regulators also suggested (Table 2).
Independent Confirmation of 2D-DIGE Changes—Immunoblot analysis in separate 
mice confirmed that alcohol drinking (intake: 12.85 ± .9 g/kg per 24 hours; 69.5 ± 3.0% 
preference) increased CaMKIIα expression (+60%, t10 = 2.5, p = .015) in amygdala (Figure 
1G) with no change in CaMKIIβ (Figure 1H). Additionally, there was a trend for an increase 
in pCaMKIIα-Thr286 expression after alcohol drinking (water: 100 ± 15.4; alcohol: 132.9 ± 
37.8, p = ns) but expression of pCaMKIIa-Thr286 relative to total CaMKIIα was unchanged 
(water: 66.24% ± 12.04; alcohol: 58.6% ± 22.84, p = ns). NSF, which regulates presynaptic 
vesicle release and postsynaptic stabilization of AMPARs (31), was increased in the 2D-
DIGE experiment (Table 1) and showed an alcohol-induced increase (+40%, t10 = 2.0, p = .
042) (Figure 1I) on protein immunoblots.
Prefrontal cortex, nucleus accumbens (NAcb), dorsal striatum, and motor cortex were also 
assessed for altered CaMKIIα or CaMKIIβ expression. Alcohol drinking increased 
CaMKIIα expression only in NAcb (p = .026, t test) with no changes in CaMKIIβ (Table S1 
in Supplement 1).
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Alcohol Drinking Increased CaMKIIα Immunoreactivity in Amygdala Subregions
Immunohistochemistry was used to characterize potential subregional effects of alcohol 
drinking on CaMKIIα expression. CaMKIIα immunoreactivity (IR) (positive cells per mm2) 
was increased in the CeA (Figure 1J, t5 = 3.9, p = .01) and lateral amygdala (LA) (Figure 
1K, t5 = 3.0, p = .02) but not basolateral amygdala (BLA) of alcohol-drinking mice, 
demonstrating subregional specificity.
Increased CaMKIIα Phosphorylation by Alcohol Reinforcement
To determine if alcohol’s positive reinforcing effects are associated with altered activation 
of CaMKIIα, mice were trained to self-administer alcohol (9% vol/vol + sucrose 2% wt/vol) 
or sucrose only (2% wt/vol) in 1-hour sessions (32). Brains were processed for pCaMKIIα-
Thr286 IR immediately after the 30th session (Figure 2A). The two groups showed 
equivalent lever-pressing behavior (Figure 2B), indicating that differences in pCaMKIIα-
Thr286 IR are unrelated to behavioral output or reward exposure. Average alcohol intake 
was 1.14 ± .1 g/kg per hour (Figure 2C), which resulted in BAC = 61 ± 10 mg/dL per hour 
(Figure 2D). Under these behavior-matched conditions, alcohol self-administration 
increased pCaMKIIα-Thr286 IR by fivefold in the CeA (Figure 2E, t12 = 2.2, p = .02) and 
1.6-fold in LA (Figure 2F, t12 = 1.9, p = .04) with no change in BLA (data not shown) 
relative to sucrose control mice, indicating that CaMKIIα activation in the CeA and LA is a 
target of self-administered alcohol. There was no change in total CaMKIIα IR in any 
amygdala subregion immediately following operant self-administration (Table S2 in 
Supplement 1), suggesting alcohol-induced activation of extant CaMKIIα.
No Effect of Acute Alcohol on CaMKIIα Phosphorylation in the Amygdala
C57BL/6J mice were administered alcohol (0–3 g/kg, intraperitoneal) before a 30-minute 
locomotor test (Figure 2G). Acute alcohol produced a biphasic effect (F2,29 = 11.5, p = .002) 
on locomotor activity (Figure 2H) but did not alter pCaMKIIα-Thr286 IR in the CeA 
(Figure 2I–J) or LA (mean ± SEM cells/mm2: 0 mg/kg = 784.6 ± 56.37; 1 mg/kg = 747.1 ± 
86.76; 3 mg/kg = 840.5 ± 173.1) immediately after locomotor sessions.
CaMKII Activity in the Amygdala Is Required for Alcohol Reinforcement
To determine if CaMKII activity in the amygdala regulates the positive reinforcing effects of 
alcohol, we site-specifically inhibited CaMKII in the amygdala before operant self-
administration sessions (33–35) (Figure 3A,B). The cell-permeable CaMKII inhibitor 
KN-93 (10 μg/.5 μL, n = 8 mice) decreased alcohol-reinforced responding (t7 = 2.5, p = .04) 
without altering locomotor activity (Figure 3C). Since KN-93 also blocks voltage-gated 
potassium channels in a CaMKII-independent manner, we examined effects of the selective 
cell-permeable inhibitor m-AIP, which binds to the calmodulin site and inhibits CaMKII 
activation (36). Intra-amygdala infusion of m-AIP produced a dose-dependent reduction in 
alcohol-reinforced responding (F3,6 = 10.4, p = .002) with no effect on sucrose self-
administration or locomotor activity (Figure 3D). Infusion of scrambled m-AIP had no effect 
(Figure 3D, left). We also examined effects of CaMKIIN-tide, an endogenous peptide 
inhibitor that blocks both CaMKII activation and autophosphorylation (37). Intra-amygdala 
infusion of CaMKIINtide significantly reduced alcohol-reinforced responding (F3,18 = 5.3, p 
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= .0026) with no effect on sucrose reinforcement or locomotor activity (Figure 4E). 
Scrambled CaMKIINtide had no effect (Figure 3E, left).
Alcohol Drinking Increases AMPAR GluA1 Phosphorylation and Synaptic Activity in CeA
A primary function of CaMKII is to phosphorylate the AMPAR GluA1 subunit at Ser831, 
which leads to potentiation of AMPAR-mediated synaptic activity and regulation of 
behavioral processes (38,39) (Figure S1 in Supplement 1). Thus, we sought to determine if 
voluntary home-cage alcohol dinking increases AMPAR GluA1 phosphorylation and 
synaptic activity (Figure 4A). Dual-label fluorescent immunohistochemistry with confocal 
visualization showed that CeA neurons co-express CaMKIIα and GluA1 (Figure 4B). 
Further, home-cage alcohol drinking (24 days) increased pGluA1-Ser831 IR (CaMKII 
recognition site) in the CeA (Figure 4C,E; t12 = 2.5, p = .026) but not in the LA (Figure 
4D,E; t14 = .5, p = .65). To determine if increased GluA1-Ser831 activation is associated 
with increased synaptic activity, we examined effects of voluntary alcohol drinking on 
glutamatergic synaptic activity in the CeA. C57BL/6J mice consumed alcohol (10% vol/vol; 
mean intake: 13.2l ± l.25 g/kg per day) or water for 24 days under the two-bottle drinking 
procedure. AMPA/N-methyl-D-aspartate (NMDA) ratio was increased in CeA neurons from 
alcohol mice (Figure 4F,G; t27 = 3.1, p = .004). Paired-pulse ratio was not different between 
alcohol (1.29 ± .19) and control mice (1.45 ± .13). However, CeA neurons from alcohol 
mice showed increased spontaneous excitatory postsynaptic current (sEPSC) frequency 
(Figure 4F,G; t32 = 2.7, p = .009) with no change in amplitude (alcohol: 21.4 ± 1.2, water: 
21.0 ± 1.3).
AMPAR Activity in the CeA Regulates the Reinforcing Effects of Alcohol
To determine if AMPAR activity in the amygdala is required for alcohol reinforcement, we 
investigated whether operant self-administration of alcohol is associated with increased 
GluA1 activation. Mice were trained to lever-press with sweetened alcohol or sucrose 
reinforcement. The two groups were behavior-matched and earned an equal number of 
reinforcers, and alcohol intake was 1.3 ± .1 g/kg per hour. Immediately after the 30th self-
administration session, brains were processed for pGluA1-Ser831 IR (Figure 5A). Operant 
alcohol self-administration increased pGluA1-Ser831 IR by twofold in CeA (Figure 5B,D; 
t14 = 2.2, p = .04) and LA (Figure 5C,D; t14 = 2.1, p = .03) relative to sucrose, indicating 
that GluA1-containing AMPARs in the CeA are a target of self-administered alcohol. 
Separate mice were then surgically implanted with guide cannulae and the competitive 
AMPAR antagonist NBQX (0–3 μg/.5 μL, n = 10) was infused in CeA before operant self-
administration sessions (Figure 5A,E). NBQX infusion in CeA significantly reduced 
sweetened alcohol-self-administration (Figure 5F; t9 = 5.8, p = .0003) but had no effect on 
sucrose-reinforced responding or open-field locomotor activity in separate tests (data not 
shown).
DISCUSSION
Effects of Voluntary Alcohol Drinking on the Amygdala Proteome
This study was designed to increase understanding of the etiology of alcohol addiction by 
identifying protein networks that are targeted by voluntary alcohol drinking in the amygdala, 
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a key set of nuclei that mediate drug reward and reinforcement (8). A high throughput 
proteomic screen identified 29 individual proteins and two networks that were differentially 
expressed after 24 days of alcohol drinking in nondependent mice. IPA identified significant 
overexpression of alcohol-sensitive proteins in networks that regulate bipolar disorder, 
schizophrenia, and depression, suggesting novel pathways by which alcohol drinking may 
alter the predisposition or course of neuropsychiatric disorders (41). Moderate alcohol 
drinking also altered proteins associated with cell morphology, energy balance, and 
metabolism, which are critical to brain function. Potential upstream regulators were linked 
to Alzheimer’s disease, fragile X syndrome, and Huntington’s disease indicating that 
moderate alcohol use may interact with a variety of conditions across the life span (41).
These findings support prior proteomic and genomic work. For instance, alcohol drinking 
reduced HSPA8 in the amygdala of alcohol-preferring rats (18). DPYSL2 (CRMP-2), 
ENO1, HK1, HSP90AA1, MDH1, PGAM1, and STXBP1 were altered in cortex and 
midbrain of alcohol-dependent, nondependent, and control C57BL/6J mice (19). ENO1, 
HSPA8, PGAM1, and STXBP1 were reported in at least four alcohol-related proteomic 
studies [reviewed by (22)]. Genomic studies of alcohol response identified 13 of the 29 
alcohol-sensitive targets detected in this study, including Kif5c, NSF, PAFAH1B1, and 
STXBP1, in rodents and humans (Table S3 in Supplement 1). These findings suggest that 
effects of alcohol drinking we observed in nondependent mice may translate to later stages 
of alcohol addiction as modeled in dependent rodents and directly assessed in postmortem 
human alcoholic studies.
Importantly, protein networks that regulate cell signaling and plasticity were altered by 
alcohol drinking. Prominent in this cluster was CaMKIIα, which is a principal mechanism of 
synaptic function including driving AMPARs to the synapse during long-term potentiation 
(42,43). Proteins linked to CaM-KII and AMPAR function were also increased, including 
KiF5C, a molecule that shuttles CaMKIIα and AMPAR GluA2 subunits to the postsynaptic 
density (44); EEF2, an elongation factor that modulates CaMKIIα messenger RNA 
translation (45); and NSF, an adenosine triphosphatase that stabilizes synaptic AMPARs 
(31). Additionally, NSF and STXBP-1 play significant roles in calcium (Ca2+)-dependent 
synaptic vesicle exocytosis during neurotransmitter release (46) and alcohol drinking (47). 
Collectively, these proteins represent potential cellular machinery for increasing CaMKII 
expression or activity and upregulation of AMPAR synaptic activity, which suggests 
enhanced glutamate transmission in the early stages of alcohol addiction.
Effect of Alcohol Drinking and Operant Self-Administration on Amygdala CaMKIIα 
Expression and Activation
CaMKII is a family of Ca2+-activated Ser/Thr protein kinases that mediate many 
intracellular responses in the brain including regulation of ion channels, neurotransmitter 
synthesis and release, and synaptic plasticity (16). Here, we sought to determine if alcohol 
drinking alters CaMKII protein expression and activation in brain regions known to regulate 
behavioral plasticity and drug self-administration. Results showed that moderate drinking 
increased CaMKIIα expression in mouse amygdala and NAcb, brain regions that regulate 
alcohol reinforcement (48,49). No change occurred in CaMKIIβ or in CaMKII (α or β) 
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expression in other brain regions examined. Further, immunohistochemistry results showed 
that alcohol drinking-induced increases in CaMKIIα expression in the amygdala were 
localized to the CeA and LA, indicating subregional specificity. Since CaMKII expression 
characterizes amygdala projection neurons (50), these results may indicate alcohol-enhanced 
neuronal output from LA and CeA to target regions, such as the NAcb.
CaMKIIα is activated when neuronal depolarization leads to Ca2+ entry in the cell. 
Calmodulin then binds calcium and the Ca2+/calmodulin complex leads to CaMKIIα 
phosphorylation at Thr286 (pCaMKIIa-Thr286). CaMKIIα activation in the amygdala is 
required for certain types of behavioral plasticity (51). In our experiments, lever-press 
responding maintained by alcohol increased pCaMKIIα-Thr286 IR in the CeA and LA as 
compared with behavior-matched sucrose control mice, indicating that differential CaMKIIα 
phosphorylation is alcohol-specific and not associated with general learning or context 
effects. Moreover, acute alcohol injection had no effect, suggesting that CaMKIIα 
phosphorylation in the amygdala may represent an adaptive response to alcohol self-
administration or repeated exposure. Given the critical role of CaMKIIα in associative 
learning and memory (52), these findings suggest that alcohol drinking-induced upregulation 
of CaMKIIα expression and activation may reflect increased learning about the drug and 
associated stimuli.
CaMKII Activation in the Amygdala: A Novel Mechanism of Alcohol’s Reinforcing Effects
CaMKII is an ideal molecular candidate for initiating and sustaining maladaptive plasticity 
in reinforcement processes in the early stages of alcohol addiction due to its prominent role 
in normal, or adaptive, cellular and behavioral plasticity (53). However, the extent to which 
CaMKIIα regulates the positive reinforcing effects of alcohol was unknown. To address this 
gap in knowledge, we assessed the effects of site-specific pharmacologic inhibition of 
CaMKII activity in the amygdala of separate groups of behavior-matched mice trained to 
lever-press for sweetened alcohol or sucrose only reinforcement. Results showed that 
bilateral microinjection of the CaMKII inhibitor KN-93 in the amygdala significantly 
decreased alcohol-reinforced lever presses in the absence of nonspecific motor effects. To 
further delineate the mechanistic role of CaMKII in alcohol reinforcement, we evaluated 
effects of the highly selective CaMKII inhibitor m-AIP, which binds directly to the 
calmodulin site and prevents initial CaMKII activation (e.g., phosphorylation) (35). m-AIP 
produced a dose-dependent reduction in alcohol-reinforced responses without effect on 
behavior-matched sucrose control mice or locomotor activity. No effects of scrambled m-
AIP were observed on alcohol reinforcement. Second, behavioral tests were conducted 
following amygdala infusion of m-CaMKIIN-tide, a cell-permeable peptide inhibitor that 
blocks both Ca2+/calmodulin phosphorylation and Ca2+-independent autophos-phorylation 
of CaMKII (36). m-CaMKIINtide produced a dose-dependent and selective reduction in 
alcohol-reinforced responding with similar potency and efficacy of m-AIP. These data 
indicate that the positive reinforcing effects of alcohol require initial Ca2+-calmodulin 
activation of CaMKII in the amygdala and that Ca2+-independent autophosphorylation may 
not regulate alcohol reinforcement.
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Alcohol Drinking Increases AMPAR-Mediated Synaptic Activity in the CeA
Following activation, cytoplasmic CaMKII can translocate to the cell membrane where it 
potentiates AMPAR-mediated activity via phosphorylation of GluA1-Ser831 (26,37). 
Results of this study show that neurons in the CeA co-express CaMKIIα and GluA1 and that 
alcohol drinking increases pGluA1-Ser831 IR in the CeA, suggesting an anatomical basis by 
which alcohol drinking might increase AMPAR activity.
To address potential changes in AMPAR function, we measured AMPA/NMDA ratio as an 
index of synaptic strength (54,55). Alcohol-drinking mice showed increased AMPA/NMDA 
ratios, suggesting that voluntary alcohol intake increases synaptic drive in the CeA. Since 
exposure to chronic ethanol vapor increases ethanol-induced glutamate levels in CeA (9), we 
measured response to paired pulses as an index of probability of transmitter release (56). 
Paired-pulse ratio was not different between alcohol and water control mice. Spontaneous 
excitatory postsynaptic currents were also examined to characterize potential synaptic sites 
of action. Alcohol-drinking mice showed an increase in sEPSC frequency but no change in 
amplitude. An increase in the frequency of sEPSCs in the absence of change in paired-pulse 
ratio may indicate an increase in the number of functional AMPARs at previously silent 
synapses (55,57). A potential mechanism for increased AMPA-mediated synaptic activity is 
that alcohol increased expression of NSF in the amygdala (Tables 1 and 2; Figure 1), which 
promotes surface expression and increased function of AMPARs (31,58). This is 
complementary to evidence showing that alcohol dependence is associated with increased 
excitatory postsynaptic current amplitude, GluA1 surface expression, GluA1-Ser831 
phosphorylation, and CaMKIIα-Thr286 phosphorylation in rat BLA (11). Together, these 
findings suggest that voluntary alcohol drinking during the nondependent state initiates 
molecular adaptations in amygdala CaMKIIα and AMPAR signaling that subsequently 
characterize dependence.
AMPARs in the Amygdala Regulate the Reinforcing Effects of Alcohol
To determine if AMPAR activity in the amygdala regulates the positive reinforcing effects 
of alcohol, we first examined pGluA1-Ser831 IR in the amygdala immediately after an 
operant alcohol self-administration session. pGluA1-Ser831 IR was increased in the CeA 
and LA by twofold as compared with sucrose control mice, indicating a specific effect of 
alcohol on AMPAR GluA1 activation that is independent of motor activity or general 
reinforcement processes. Next, we infused the AMPAR antagonist NBQX (0 or 3 μg/μL) in 
the amygdala before self-administration sessions. NBQX significantly reduced operant 
alcohol self-administration but had no effect in parallel behavior-matched sucrose-only 
control mice or in locomotor activity tests. These results indicate that operant alcohol self-
administration rapidly increases AMPAR phosphorylation at a CaMKII substrate (GluA1-
Ser831) and that AMPAR activity in the amygdala is required for alcohol’s positive 
reinforcing effects. Given the prepotency of positive reinforcement during the initial stages 
of addiction, this suggests that AMPAR activity in the amygdala may play a critical role in 
the etiology of alcoholism. It will be important to extend the current work to determine if 
identified mechanisms of positive reinforcement regulate aspects of pathological drinking in 
rodent models that characterize abuse and dependence (59).
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Conclusion
Alcohol addiction is a pathological progression that ranges from initial drug use to abuse. In 
this study, we sought to shed new light on the neurobiological changes that occur in the 
brain during the initial use stage of alcohol addiction. Taking an unbiased proteomic 
approach, we found that a relatively short duration (24 days) of voluntary alcohol drinking 
altered expression of key plasticity-linked protein networks in mouse amygdala that, in turn, 
regulate the positive reinforcing properties of alcohol. Functional proteomic studies that 
identify the pleiotropic neural targets of initial alcohol use and validate their mechanistic 
significance in animal behavioral models are essential for a complete understanding of the 
etiology of alcohol addiction.
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Figure 1. 
Effects of voluntary alcohol drinking on the amygdala proteome. (A) Timeline of 
experimental procedures. (B) (top) Alcohol (EtOH) (n = 12) and water (H2O) (n = 12) 
exposed mice showed equal daily total fluid intake. (B) (bottom) Alcohol ntake stabilized 
after 5 days and reached a mean (±SEM) of 12.8 g/kg per day. (C) Alcohol drinking 
produced no change in levels of the stress hormone corticosterone (CORT) measured at the 
time of sacrifice. (D) Schematic (left) and photomicrograph (right) of mouse brain section 
showing location of amygdala tissue punch for two-dimensional differential in-gel 
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electrophoresis (2D-DIGE) and immunoblot studies. (E) Representative 2D-DIGE gel 
showing differentially expressed proteins (circled) and labeled with spot numbers 
corresponding to Table 1. Red arrows point to N-ethylmaleimide sensitive factor (NSF) 
(spot 11) and calcium/calmodulin dependent kinase II alpha (CaMKIIα) (spot 19). (F) 
Standardized abundance (log) showing significant (p = .006, t test) alcohol-nduced change 
in CaMKIIα averaged across four replicate 2D gels. (G–I) Representative immunoblots (n = 
6/group) and quantitative analysis showing that alcohol drinking significantly increased 
CaMKIIα and NSF but produced no change in calcium/calmodulin dependent kinase II beta 
(CaMKIIβ) in the amygdala (CeA) relative to water control mice. Data are relative to 
glyceraldehyde-3-phos-phate dehydrogenase (GAPDH). (J,K) Representative images and 
quantitative data showing alcohol drinking-nduced increase in CaMKIIα immunoreactivity 
(IR) in CeA and lateral amygdala (LA) as compared with H2O control mice. Data are 
expressed as mean (±SEM). Asterisks indicate significantly different from water (*p < .
05; **p < .01), t test. IHC, immunohistochemistry; OD, optical density.
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Figure 2. 
Operant alcohol self-administration, but not acute injection, increases calcium/calmodulin 
dependent kinase II alpha (CaMKIIα)-Thr286 phosphorylation in the amygdala. (A) 
Timeline of experimental procedures evaluating CaMKIIα phosphorylation after operant 
alcohol self-administration (Self-Admin). (B) Total alcohol (EtOH) (n = 7) and sucrose 
(Suc) (n = 7) reinforced lever-presses as a function of daily 1-hour behavioral test sessions. 
(C,D) Dosage of EtOH self-administered (g/kg) and resultant blood alcohol concentration 
(BAC) immediately after the 1-hour session. (E,F) Representative photomicrographs of the 
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cytological pattern of phosphorylated CaMKIIα (pCaMKIIα)-Thr286 immunoreactivity (IR) 
in the central amygdala (CeA) and lateral amygdala (LA) (right) and analysis (left) showing 
that operant alcohol self-administration increased pCaMKIIα-Thr286 IR (cells/mm2) in both 
the CeA and LA. Data represent mean (±SEM) of multiple brain sections from n = 7 mice 
per condition (*p < .05), t test. (G) Timeline of experiment evaluating effects of acute 
ethanol injection on locomotor activity and CaMKIIα-Thr286 immunoreactivity. (H–J) 
Acute EtOH (0–3 g/kg) produced a biphasic effect on locomotor activity (*p < .05 vs. EtOH 
[0 g/kg] Dunnett’s test) but no effect on CaM-KIIα-Thr286 phosphorylation in the CeA or 
LA (not shown). IHC, immuno-histochemistry; IP, intraperitoneal.
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Figure 3. 
Calcium/calmodulin dependent kinase II (CaMKII) activity in the amygdala is required for 
the reinforcing effects of alcohol. (A) Procedural timeline showing number of days during 
each experimental phase of alcohol (EtOH) and sucrose (Suc) self-administration (Self-
Admin). (B) Illustration of drug infusion sites in the amygdala from alcohol/sucrose (red) 
and sucrose (blue) self-administering mice. (C) Total EtOH reinforced responses (n = 8) 
during 1-hour sessions plotted as a percentage of artificial cerebrospinal fluid (ACSF) 
control (left) and locomotor activity plotted as a function of KN-93 dosage (*p < .05 vs. 
vehicle, t test). (D,E) Effects of CaMKII peptide inhibitors (myristoylated autocamtide-2-
related inhibitory peptide [m-AIP] and CaMKII Ntide) on alcohol (m-AIP n = 7; Ntide n = 
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6) and sucrose (m-AIP n = 7; Ntide n = 5) self-administration and locomotor activity. 
Figures represent EtOH (left) and sucrose (middle) reinforced responses and locomotor 
activity (right) during 1-hour sessions plotted as a function of m-AIP (D) or CaMKII Ntide 
(E) dosage. Scrambled peptide (S) was tested at a single dose for each inhibitor as negative 
controls to show that a specific sequence rather than the amino acid composition is critical 
for activity. *p < .05 versus vehicle, Dunnett’s multiple comparison test. [Images in (B) are 
based on coordinates from Paxinos and Franklin (40)].
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Figure 4. 
Effect of voluntary alcohol drinking on α-amino-3-hydroxy-5-methyl-4-isooxazole receptor 
(AMPAR) GluA1-ser831 phosphorylation and glutamate-mediated synaptic activity in the 
central amygdala (CeA). (A) Timeline of experimental procedures evaluating effects of 
voluntary home-cage alcohol (EtOH) drinking on GluA1-ser831 immunoreactivity (IR) and 
glutamate-mediated synaptic activity in the CeA. (B) Confocal microscopy image showing 
immuno-cytochemical co-expression of calcium/calmodulin dependent kinase II alpha 
(CaMKIIα) and AMPA GluA1 subunit in CeA of untreated mice. (C,D) 
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Immunohistochemistry (IHC) results showing increased activation (e.g., phosphorylation) of 
GluA1 at the CaMKIIα recognition site (pGluA1-Ser831) in alcohol-drinking mice in the 
CeA but no change in the lateral amygdala (LA). (E) Photomicrograph showing the 
cytological expression of pGluA1-ser831 in subregions of the amygdala. (F) Significant 
increase in AMPA/N-methyl-D-aspartate (NMDA) ratio and AMPA-mediated spontaneous 
excitatory postsynaptic current (sEPSC) frequency as a function of alcohol drinking. (G) 
Tracings show currents from water (H2O)- (n = 8) and alcohol- (n = 8) drinking mice. 
Asterisks indicate the following: *p < .05; **p < .001, t test. BLA, basolateral amygdala.
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Figure 5. 
Operant alcohol self-administration increases α-amino-3-hydroxy-5-methyl-4-isooxazole 
receptor (AMPAR) GluA1-ser831 phosphorylation in amygdala subregions and AMPAR 
activity is required for the reinforcing effects of alcohol (EtOH). (A) Procedural timeline 
showing number of days during each experimental phase of alcohol and sucrose (Suc) self-
administration (Self-Admin). (B,C) Operant alcohol self-administration (n = 7) increased 
AMPAR pGluA1-Ser831 immunoreactivity (IR) in the central amygdala (CeA) and lateral 
amygdala (LA) as compared with sucrose control mice (n = 7). (D) Representative images of 
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coronal sections of the amygdala showing subregional specificity of alcohol-nduced increase 
in pGluA1-Ser831 from sucrose and EtOH + sucrose (EtOH/Suc) self-administering mice. 
(E) Representative photomicrograph of coronal brain section showing injector track in CeA 
juxtaposed with mouse brain atlas. (F) Intra-amygdala infusion of the AMPAR antagonist 
NBQX significantly reduced alcohol self-administration (n = 10) during 1-hour session. 
Asterisks indicate the following: *p < .05; ***p < .001, t test. BLA, basolateral amygdala; 
IHC, immunohistochemistry.
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Table 2
Involvement of Differentially Expressed Proteins in Neural Networks and Functions Identified by Ingenuity 
Pathway Analysis
Networks Focus Proteins Protein Network
Cell Signaling and Interaction, 
Nervous System Development and 
Function, Behavior
14 AK1↓, ALDH1L1↑, ALDOA↓, APP, ATP, BASP1↑, CAMK2A↑, CAP1↓, 
CAV1, CDK5R1, DSCAM↓, EEF2↑, EGFR, EIF2AK2, ENO1↓, F2R, 
FABP3, FMR1, GDI1, GRIA1, GRIA2, HK1↑, HSP90AA1↑, HSPA8↓, 
IFNG, MAP1B, MAP2K1, MAP2K2, MECP2, MMP9, NRGN, NSF↑, 
PGAM1↓, progesterone, SNAP25
Cell Morphology, Cell Assembly 
and Organization, Cell 
Development
8 ADAM22↑, APP, CAMK2A↑, CDK5R1, DAB1, DCX, DLG2, DLG4, 
DPYSL2↓, GNB2↓, GRIN2A, GRIN2B, HTR2C, INA, KCNA2, KIF5B, 
KIF5C↑, KLC1, KLC2, LGI1, MAP1B, MBP, MT3, NEFL, NF1, NOS1, 
NSF↑, PAFAH1B1↓, PAFAH1B2, RAC1, RHOA, RTN4, RTN4R, 
STXBP1↑, TNIK
Diseases and Disorders Function p Value Proteins
Developmental Disorder Delay of brain 
development
.002 PAFAH1B1↓
Neuropsychiatric Disorder Bipolar disorder .009 CAMK2A↑, DPYSL2↓
Schizophrenia .02 DPYSL2↓, MDH1↓, PGAM1↓
Depression .03 CAMK2A↑, DPYSL2↓, ENO1↓, HK1↓
Molecular and Cellular Function p Value Proteins
Cellular Development, Function, 
and Maintenance
Microtubule dynamics 
Formation of cellular 
projections
.004
.001
AK1↓, ADAM22↑, BASP1↑, CAMK2A↑, 
DPYSL2↓, DSCAM↓, HSPA8↓, HSP90AA1↑, 
PAFAH1B1↓, KIF5C↑
Cell-To-Cell Signaling Synaptic transmission 
and plasticity, LTP
.004 CAMK2A↑, DPYSL2↓, EEF2↑, KIF5C↑, NSF↑, 
PAFAH1B1↓, STXBP1↑
Metabolism Alcohol catabolic 
process
Glucose catabolic 
process
.00001
3.0E-6
ALDOA↓, ENO1↓, HK1↑, MDH1↑, PGAM1↓
Top Canonical Pathways p Value Proteins
Glucogenesis/Glycolysis 2.0E-6 ALDOA↓, ENO1↓, HK1↑, MDH1↓, PGAM1↓
Krebs Cycle .002 FH↓, MDH↓
Top Upstream Regulators p Value Target Proteins in Dataset
MAPT (microtubule-associated protein tau)
PSEN1 (presenilin 1)
APP (amyloid beta (A4) precursor protein)
3.9E-12
1.8E-10
1.2E-09
ALDOA↓, BASP1↑, CAP1↓, DPYSL2↓, ENO1↓, 
HK1↑, HSP90AA1↑, HSPA8↓, PGAM1↓, 
STXBP1↑
FMR1 (fragile X mental retardation syndrome 1) 6.2E-09 ALDOA↓, BASP1↓, CAMK2A↑, EEF2↑, ENO1↓
HTT (huntingtin) 1.3E-03 BASP1↑, CAMK2A↑, HSPA8↓, NSF↑, STXBP1↑
Focus proteins are in bold font. Other proteins (regular font) are included in networks based on known protein interactions in the Ingenuity 
Pathway Analysis database. Arrows indicate direction of change in protein expression (↓ downregulated, ↑ upregulated) induced by alcohol 
drinking, as shown in Table 1. Protein clusters with multiple functions are noted by brackets. p values were derived in Ingenuity Pathway Analysis 
by right-tailed Fisher exact test and indicate relative overrepresentation of proteins in a given function than what is expected by chance.
LTP, long-term potentiation.
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